Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

Biomarkers research in amyotrophic lateral sclerosis (ALS) holds the promise of improving ALS diagnosis, follow-up of patients, and clinical trials outcomes. Metabolomics have a big impact on biomarkers identification. In this mini-review, we provide the main findings of metabolomics studies in ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanznaster, Débora, de Assis, Denis Reis, Corcia, Philippe, Pradat, Pierre-François, Blasco, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305341/
https://www.ncbi.nlm.nih.gov/pubmed/30619076
http://dx.doi.org/10.3389/fneur.2018.01126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305341/
https://www.ncbi.nlm.nih.gov/pubmed/30619076
http://dx.doi.org/10.3389/fneur.2018.01126

Ejemplares similares